Pseudomonas aeruginosa bacteriophage PA1Ø requires type IV pili for infection and shows broad bactericidal and biofilm removal activities

Applied and Environmental Microbiology

Volumn 78, Issue 17, 2012, Pages 6380-6385

  Kim, Shukho ^a   Rahman, Marzia ^a   Seol, Sung Yong ^a   Yoon, Sang Sun ^b,c   Kim, Jungmin ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Brain Korea 21 Project for Medical Science   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOFILM CELLS; GRAM-NEGATIVE BACTERIA; IV PILI; MIXED INFECTIONS; P.AERUGINOSA; PSEUDOMONAS AERUGINOSA; REMOVAL ACTIVITY; STAPHYLOCOCCUS AUREUS; THERAPEUTIC AGENTS;

BIOFILMS;

BACTERIA;

BACTERIOPHAGE; BACTERIUM; BIOFILM; INFECTIVITY;

ARTICLE; BACTERIOLYSIS; BIOFILM; BIOLOGICAL THERAPY; FIMBRIA; GROWTH, DEVELOPMENT AND AGING; METHODOLOGY; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PSEUDOMONAS PHAGE; VIROLOGY; VIRUS ENTRY;

BACTERIOLYSIS; BIOFILMS; BIOLOGICAL THERAPY; FIMBRIAE, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PSEUDOMONAS PHAGES; VIRUS INTERNALIZATION;

NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84866155898     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00648-12     Document Type: Article

References (19)

1. Ackermann HW. 2009. Phage classification and characterization. Methods Mol. Biol. 501:127-140.
2. Courchesne NM, Parisien A, Lan CQ. 2009. Production and application of bacteriophage and bacteriophage-encoded lysins. Recent Pat. Biotechnol. 3:37-45.
3. Darzins A, Casadaban MJ. 1989. Mini-D3112 bacteriophage transposable elements for genetic analysis of Pseudomonas aeruginosa. J. Bacteriol. 171:3909-3916.
4. Goodman AL, et al. 2004. A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. Dev. Cell. 7:745-754.
5. Humphrey SB, Stanton TB, Jensen NS, Zuerner RL. 1997. Purification and characterization of VSH-1, a generalized transducing bacteriophage of Serpulina hyodysenteriae. J. Bacteriol. 179:323-329.
6. Jessup CM, Forde SE. 2008. Ecology and evolution in microbial systems: the generation and maintenance of diversity in phage-host interactions. Res. Microbiol. 159:382-389.
7. Kim S, et al. 2010. A simple colorimetric method for testing antimicrobial susceptibility of biofilmed bacteria. J. Microbiol. 48:709-711.
8. Kim S, Rahman M, Kim J. 2012. Complete genome sequence of Pseudomonas aeruginosa lytic bacteriophage PA1O which resembles temperate bacteriophage D3112. J. Virol. 86:3400-3401.
9. Knezevic P, Petrovic O. 2008. A colorimetric microtiter plate method for assessment of phage effect on Pseudomonas aeruginosa biofilm. J. Microbiol. Methods. 74:114-118.
10. Lai MJ, et al. 2011. Antibacterial activity of Acinetobacter baumannii phage varphiAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria. Appl. Microbiol. Biotechnol. 90:529-539.
11. Mathur MD, Vidhani S, Mehndiratta PL. 2003. Bacteriophage therapy: an alternative to conventional antibiotics. J. Assoc. Phys. India. 51:593-596.
12. Matsuzaki S, et al. 2005. Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J. Infect. Chemother. 11:211-219.
13. Merabishvili M, et al. 2009. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS One 4:e4944. doi:10.1371/journal.pone.0004944.
14. Roncero C, Darzins A, Casadaban MJ. 1990. Pseudomonas aeruginosa transposable bacteriophages D3112 and B3 require pili and surface growth for adsorption. J. Bacteriol. 172:1899-1904.
15. Salmon KA, Freedman O, Ritchings BW, DuBow MS. 2000. Characterization of the lysogenic repressor (c) gene of the Pseudomonas aeruginosa transposable bacteriophage D3112. Virology. 272:85-97.
16. Sillankorva S, et al. 2011. Efficacy of a broad host range lytic bacteriophage against E. coli adhered to urothelium. Curr. Microbiol. 62:1128-1132.
17. Sulakvelidze A, Alavidze Z, Morris JG, Jr. 2001. Bacteriophage therapy. Antimicrob. Agents Chemother. 45:649-659.
18. Verbeken G, et al. 2007. European regulatory conundrum of phage therapy. Future Microbiol. 2:485-491.
19. Wang PW, Chu L, Guttman DS. 2004. Complete sequence and evolutionary genomic analysis of the Pseudomonas aeruginosa transposable bacteriophage D3112. J. Bacteriol. 186:400-410.